The most recent quarterly results show a sharp decline in gross profit margin turning negative in Q2 2026 after earlier positive margins, driven by soaring costs. Operating losses widened substantially, with operating income margin deteriorating to nearly -70%. Net income is consistently negative, reflecting prolonged unprofitability and high expenses.

Revenue remains relatively modest and has grown from $5.2 million in Q1 2026 to $8 million in Q2 2026, showing some sequential improvement. However, absolute revenue levels are low versus operating costs, pointing towards heavy early-stage investment cycles rather than near-term profitability.

Margins have suffered due to escalating research and development expenses, which comprise the largest portion of operating expenses. Gross margin fluctuated from a solid 65% in Q1 2026 to negative 29% in Q2 2026 primarily due to cost of revenue sharply increasing and outpacing sales, reflecting potential product mix or scaling inefficiencies.

Earnings quality is weak with significant net losses driven by high operating expenses and negative EBITDA margins exceeding 68% most recently. The company generates no positive cash flow from operations, relying heavily on funding and capital raising to sustain operations, raising concerns over earnings sustainability.

Year-over-year revenue rose from approximately $22.9 million in 2024 to $30.9 million in 2025, reflecting about a 35% growth. However, sequential quarterly revenue growth in 2026 shows volatility with a promising 52.7% increase from Q1 ($5.2M) to Q2 ($8M).

Earnings remain deeply negative with EPS deteriorating from -$0.48 in Q1 2026 to -$1.93 in Q2 2026, indicating worsening profitability despite revenue gains. The EPS decline contrasts with revenue growth, signaling rising cost pressures.

Growth is primarily driven by product development cycles and quantum technology commercialization efforts supplemented by increasing customer engagement. However, high R&D expenditure weighs against near-term profitability improvements.

Growth is largely organic, driven by internal innovation and increased product sales. However, the sustainability is uncertain as the company must control rising costs and successfully scale commercial uptake of its quantum offerings.

Gross margin dropped drastically from about 65% in Q1 2026 to -29% in Q2 2026. Operating margin has been negative across all recent quarters, worsening to nearly -70% in the latest quarter. Net margins remain negative, reflecting continuing losses.

Return metrics such as ROE and ROA are profoundly negative, consistent with steep net losses, though exact figures are unavailable. This reflects insufficient asset and equity utilization given current financial structure.

Current margins are not sustainable at present revenue levels and expense structure. Without significant scale economies or a breakthrough commercial product, continued losses and negative margins are expected to persist in the near term.